Soliton, Inc. (SOLY) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Devices 산업에서 운영. 본사 소재지는 Houston, TX, 미국. 현재 CEO는 Christopher C. Capelli.
SOLY 을(를) 보유 IPO 날짜 2019-02-19, 13 명의 정규직 직원, 에 상장 NASDAQ Capital Marke.
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
